Mulmit

Sol-Gel Technologies Ltd.Sol-Gel Technologies Ltd.

SLGL Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-313,800,000-7,538,000-6,127,000-2.19
2024-12-313,800,000-12,014,000-10,580,000-3.79
2022-12-310-16,244,000-14,923,000-0.65
2021-12-313,303,0002,964,0003,221,0000.14
2020-12-318,673,000-30,233,000-29,290,000-1.3

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-09Opaleye Management Inc.3,097
2026-09-08Opaleye Management Inc.3,390
2026-09-08Opaleye Management Inc.471
2026-09-04Opaleye Management Inc.918
2026-09-04Opaleye Management Inc.2,100
2026-09-02Opaleye Management Inc.900
2026-09-01Opaleye Management Inc.783
2026-08-31Opaleye Management Inc.5,000
2026-08-31Opaleye Management Inc.217
2026-08-28Opaleye Management Inc.10,000
2026-08-28Opaleye Management Inc.20,113
2026-08-28Opaleye Management Inc.5,000
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.